The UNAIDS PCB brings together civil society, cosponsors and United Nations member states to help chart the co-creation of ...
El Mundo on MSN2h
Drug that protects against HIV with two 'shots' a year, discovery of the year for 'Science'Lenacapavir, a treatment administered subcutaneously every six months, is capable of preventing infection with very high ...
A long-acting HIV treatment and prevention tool is a medication that is injected, rather than a pill, and taken less ...
COLORADO, USA — Despite life-saving medications and a plethora of resources, HIV cases in Colorado have been increasing over ...
China aims to keep its HIV prevalence rate below 0.2 percent by 2030, according to a policy document released this week, as ...
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...
Covering HIV medication is the focus of a complaint filed with the Maine Bureau of Insurance. MAINE, Maine — A complaint has ...
The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Globally, an estimated 40 million people live with HIV. Although 30·7 million of the people living with HIV have access to antiretroviral therapy, there were still 1·3 million new infections in 2022.1 ...
The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.
A trio of experts discuss the importance of early diagnosis, treatment barriers, and therapies in the pipeline for idiopathic ...
The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback